Wave Life Sciences
78 hedge funds and large institutions have $282M invested in Wave Life Sciences in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 24 closing their positions.
140% more call options, than puts
Call options by funds: $3.3M | Put options by funds: $1.38M
21% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 24
19% more capital invested
Capital invested by funds: $236M → $282M (+$45.6M)
1.12% more ownership
Funds ownership: 86.03% → 87.15% (+1.1%)
13% less funds holding
Funds holding: 90 → 78 (-12)
50% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$14.4M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$8.3M |
| 3 |
Morgan Stanley
New York
|
+$5.23M |
| 4 |
JP Morgan Chase
New York
|
+$4.27M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$1.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$7.95M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$6.43M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$3.4M |
| 4 |
Goldman Sachs
New York
|
-$2.38M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.86M |
WVE Hedge Fund Activity: Q1 2020 in Review
78 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2020, worth a combined $282M — up 19% from $236M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of WVE and 12 opened new positions — a net loss of 12 holders — while 24 trimmed existing stakes and 29 added.
The largest buyer was RTW Investments, adding an estimated $14.4M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $7.95M sold.
- 78 institutional investors held Wave Life Sciences (WVE) as of Q1 2020, down from 90 in Q4 2019.
- Funds reported $282M of Wave Life Sciences stock for Q1 2020, up 19% quarter-over-quarter.
- 12 funds opened new Wave Life Sciences positions in Q1 2020 and 24 closed out, a net change of -12 holders.
- The largest Wave Life Sciences buyer in Q1 2020 was RTW Investments, an estimated $14.4M added.
- The largest Wave Life Sciences seller in Q1 2020 was ArrowMark Colorado Holdings, an estimated $7.95M sold.
Based on aggregated 13F filings for Q1 2020.